These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14610124)

  • 1. Assessment of cognition in Parkinson's disease.
    Marinus J; Visser M; Verwey NA; Verhey FR; Middelkoop HA; Stiggelbout AM; van Hilten JJ
    Neurology; 2003 Nov; 61(9):1222-8. PubMed ID: 14610124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
    Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease.
    Caslake R; Summers F; McConachie D; Ferris C; Gordon J; Harris C; Caie L; Counsell C
    Curr Aging Sci; 2013 Dec; 6(3):273-9. PubMed ID: 23773030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
    Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
    Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in Parkinson's disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1182-7. PubMed ID: 17442759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC.
    Visser M; Verbaan D; van Rooden SM; Stiggelbout AM; Marinus J; van Hilten JJ
    Mov Disord; 2007 Nov; 22(15):2221-8. PubMed ID: 17712843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).
    Isella V; Mapelli C; Morielli N; De Gaspari D; Siri C; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Veglia M; Piamarta F; Grassi F; Appollonio IM
    Funct Neurol; 2013; 28(2):121-5. PubMed ID: 24125562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease.
    Evans T; Jefferson A; Byrnes M; Walters S; Ghosh S; Mastaglia FL; Power B; Anderton RS
    J Neurol Sci; 2017 Apr; 375():86-91. PubMed ID: 28320196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.
    Carod-Artal FJ; Ribeiro Lda S; Kummer W; Martinez-Martin P
    Mov Disord; 2010 Jan; 25(2):205-12. PubMed ID: 19938162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.
    Marinus J; Visser M; Stiggelbout AM; Rabey JM; Martínez-Martín P; Bonuccelli U; Kraus PH; van Hilten JJ
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):388-95. PubMed ID: 14966153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.
    Sung YH; Kim HJ; Koh SB; Kim JS; Kim SJ; Cheon SM; Cho JW; Kim YJ; Ma HI; Park MY; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Kim JY; Kwon DY; Lee JH; Lee JY; Kim JS; Yun JY; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Ahn TB
    J Korean Med Sci; 2018 Jan; 33(2):e14. PubMed ID: 29215823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
    Hobson P; Meara J
    Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.